BIO-key International (BKYI) Scheduled to Post Quarterly Earnings on Monday

Share on StockTwits

BIO-key International (NASDAQ:BKYI) will be issuing its quarterly earnings data after the market closes on Monday, April 1st.

Shares of NASDAQ:BKYI opened at $1.24 on Monday. BIO-key International has a 1 year low of $0.75 and a 1 year high of $3.64.

Separately, ValuEngine cut BIO-key International from a “buy” rating to a “hold” rating in a report on Wednesday, January 2nd.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Zolmax and is owned by of Zolmax. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://zolmax.com/investing/bio-key-international-bkyi-scheduled-to-post-quarterly-earnings-on-monday/2988387.html.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications.

Further Reading: What is the downside to momentum investing?

Earnings History for BIO-key International (NASDAQ:BKYI)

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

DBV TECHNOLOGIE/S  Given Average Rating of “Hold” by Analysts
DBV TECHNOLOGIE/S Given Average Rating of “Hold” by Analysts
Cypress Semiconductor Co.  Receives Average Recommendation of “Buy” from Brokerages
Cypress Semiconductor Co. Receives Average Recommendation of “Buy” from Brokerages
Ecolab Inc.  Receives Consensus Rating of “Hold” from Analysts
Ecolab Inc. Receives Consensus Rating of “Hold” from Analysts
ValuEngine Upgrades Bank of America  to Hold
ValuEngine Upgrades Bank of America to Hold
ValuEngine Lowers Antero Midstream Partners  to Sell
ValuEngine Lowers Antero Midstream Partners to Sell
Eurofins Scientific  Rating Increased to Hold at Zacks Investment Research
Eurofins Scientific Rating Increased to Hold at Zacks Investment Research


 
© 2006-2019 Zolmax.